Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 177

1.

[CEA in nipple discharge].

Yagihashi A.

Nihon Rinsho. 2010 Jul;68 Suppl 7:678-80. Japanese. No abstract available.

PMID:
20960849
2.

[Anti-survivin and anti-livin antibodies].

Yagihashi A.

Nihon Rinsho. 2010 Jun;68 Suppl 6:708-10. Japanese. No abstract available.

PMID:
20942170
3.

Clinical and immunological evaluation of anti-apoptosis protein, survivin-derived peptide vaccine in phase I clinical study for patients with advanced or recurrent breast cancer.

Tsuruma T, Iwayama Y, Ohmura T, Katsuramaki T, Hata F, Furuhata T, Yamaguchi K, Kimura Y, Torigoe T, Toyota N, Yagihashi A, Hirohashi Y, Asanuma H, Shimozawa K, Okazaki M, Mizushima Y, Nomura N, Sato N, Hirata K.

J Transl Med. 2008 May 10;6:24. doi: 10.1186/1479-5876-6-24.

4.

A case of anaplastic pleomorphic xanthoastrocytoma presenting with tumor bleeding and cerebrospinal fluid dissemination.

Asano K, Miyamoto S, Kubo O, Kikkukawa T, Yagihashi A, Ohkuma H.

Brain Tumor Pathol. 2006 Apr;23(1):55-63.

PMID:
18095120
5.

Protective mechanism of beta-SQAG9 liposome, a sulfonoglycolipid extracted from sea urchin intestines, against hepatic ischemia reperfusion injury.

Shima H, Tsuruma T, Sahara H, Takenouchi M, Takahashi N, Iwayama Y, Yagihashi A, Watanabe N, Sato N, Hirata K.

Shock. 2007 Jul;28(1):94-100.

PMID:
17483740
6.

Human beta-defensin-3 induction in H. pylori-infected gastric mucosal tissues.

Kawauchi K, Yagihashi A, Tsuji N, Uehara N, Furuya D, Kobayashi D, Watanabe N.

World J Gastroenterol. 2006 Sep 28;12(36):5793-7.

7.

Optimal prewarming conditions for Rh antibody testing.

Endoh T, Kobayashi D, Tsuji N, Tanabe H, Koshida S, Yagihashi A, Watanabe N.

Transfusion. 2006 Sep;46(9):1521-5.

PMID:
16965579
8.

[Detection of autoantibody against cancer antigen and its clinical application].

Yagihashi A.

Nihon Naika Gakkai Zasshi. 2006 Jul 10;95(7):1382-6. Japanese. No abstract available.

PMID:
16893037
9.

Introduction of a survivin gene-specific small inhibitory RNA inhibits growth of pancreatic cancer cells.

Tsuji N, Asanuma K, Kobayashi D, Yagihashi A, Watanabe N.

Anticancer Res. 2005 Nov-Dec;25(6B):3967-72.

10.

Autoantibodies to survivin in patients with chronic hepatitis and hepatocellular carcinoma.

Yagihashi A, Asanuma K, Kobayashi D, Tsuji N, Torigoe T, Sato N, Watanabe N.

Autoimmunity. 2005 Sep;38(6):445-8.

PMID:
16278150
11.

[CEA in nipple discharge].

Yagihashi A.

Nihon Rinsho. 2005 Aug;63 Suppl 8:635-6. Review. Japanese. No abstract available.

PMID:
16149598
12.

[Immunologic tests: Anti-Survivin and anti-Livin antibodies].

Yagihashi A.

Nihon Rinsho. 2005 Jul;63 Suppl 7:637-9. Review. Japanese. No abstract available.

PMID:
16111355
13.

Detection of autoantibodies to survivin and livin in sera from patients with breast cancer.

Yagihashi A, Ohmura T, Asanuma K, Kobayashi D, Tsuji N, Torigoe T, Sato N, Hirata K, Watanabe N.

Clin Chim Acta. 2005 Dec;362(1-2):125-30. Epub 2005 Jul 18.

PMID:
16026775
14.

Beclin 1 augmented cis-diamminedichloroplatinum induced apoptosis via enhancing caspase-9 activity.

Furuya D, Tsuji N, Yagihashi A, Watanabe N.

Exp Cell Res. 2005 Jul 1;307(1):26-40. Epub 2005 Mar 31.

PMID:
15922724
15.

Detection of autoantibodies to livin and survivin in Sera from lung cancer patients.

Yagihashi A, Asanuma K, Kobayashi D, Tsuji N, Shijubo Y, Abe S, Hirohashi Y, Torigoe T, Sato N, Watanabe N.

Lung Cancer. 2005 May;48(2):217-21. Epub 2005 Jan 8.

PMID:
15829321
16.
17.

Treatment with beta-SQAG9 prevents rat hepatic ischemia-reperfusion injury.

Shima H, Tsuruma T, Sahara H, Takenouchi M, Takahashi N, Iwayama Y, Yagihashi A, Watanabe N, Sato N, Hirata K.

Transplant Proc. 2005 Jan-Feb;37(1):417-21.

PMID:
15808663
19.

Expression of survivin mRNA and livin mRNA in non-small-cell lung cancer.

Tanabe H, Yagihashi A, Tsuji N, Shijubo Y, Abe S, Watanabe N.

Lung Cancer. 2004 Dec;46(3):299-304.

PMID:
15541814
20.

Synthetic sulfonolipids deduced from sulfonoquinovosyl diacylglycerols of sea urchin reduces hepatic ischemia-reperfusion injury in rats.

Tsuruma T, Sahara H, Takenouchi M, Yagihashi A, Iwayama Y, Shima H, Furuhata T, Torigoe T, Hanashima S, Yamazaki T, Sugawara F, Mizushina Y, Ohta K, Sakaguchi K, Sato N, Hirata K.

Transplant Proc. 2004 Sep;36(7):1965-9.

PMID:
15518713
21.

Mutations of the p53 gene and loss of heterozygosity at chromosome 17p13.1 are associated with increased survivin expression in breast cancer.

Tsuji N, Furuse K, Asanuma K, Furuya M, Kondoh K, Kamagata C, Sasaki M, Kobayashi D, Yagihashi A, Takahashi H, Watanabe N.

Breast Cancer Res Treat. 2004 Sep;87(1):23-31.

PMID:
15377848
22.

Phase I clinical study of anti-apoptosis protein, survivin-derived peptide vaccine therapy for patients with advanced or recurrent colorectal cancer.

Tsuruma T, Hata F, Torigoe T, Furuhata T, Idenoue S, Kurotaki T, Yamamoto M, Yagihashi A, Ohmura T, Yamaguchi K, Katsuramaki T, Yasoshima T, Sasaki K, Mizushima Y, Minamida H, Kimura H, Akiyama M, Hirohashi Y, Asanuma H, Tamura Y, Shimozawa K, Sato N, Hirata K.

J Transl Med. 2004 Jun 13;2(1):19.

23.

Displacement of central sulcus in cerebral arteriovenous malformation situated in the peri-motor cortex as assessed by magnetoencephalographic study.

Shimamura N, Ohkuma H, Ogane K, Manabe H, Yagihashi A, Kikkawa T, Suzuki S.

Acta Neurochir (Wien). 2004 Apr;146(4):363-8; discussion 368. Epub 2004 Feb 23.

PMID:
15057530
24.
25.

Apoptosis of auditory neurons following central process injury.

Sekiya T, Yagihashi A, Shimamura N, Asano K, Suzuki S, Matsubara A, Namba A, Shinkawa H.

Exp Neurol. 2003 Dec;184(2):648-58.

PMID:
14769356
26.

Survivin as a predictor of cis-diamminedichloroplatinum sensitivity in gastric cancer patients.

Nakamura M, Tsuji N, Asanuma K, Kobayashi D, Yagihashi A, Hirata K, Torigoe T, Sato N, Watanabe N.

Cancer Sci. 2004 Jan;95(1):44-51.

27.

A case of definitely congenital glioblastoma manifested by intratumoral hemorrhage.

Shimamura N, Asano K, Ogane K, Yagihashi A, Ohkuma H, Suzuki S.

Childs Nerv Syst. 2003 Nov;19(10-11):778-81. Epub 2003 Sep 13.

PMID:
13680296
28.

The effects of epirubicin hydrochloride (EPI) plus pretreatment of medroxyprogesterone acetate (MPA) on FM3A breast cancer cells transplanted in female C3H/He mice.

Yuyama Y, Yagihashi A, Hirata K, Suzuki Y, Ohmura T, Okazaki M, Watanabe N.

In Vivo. 2003 May-Jun;17(3):251-4.

PMID:
12929575
29.

PCD1, a novel gene containing PDZ and LIM domains, is overexpressed in human breast cancer and linked to lymph node metastasis.

Sasaki M, Tsuji N, Furuya M, Kondoh K, Kamagata C, Kobayashi D, Yagihashi A, Watanabe N.

Anticancer Res. 2003 May-Jun;23(3B):2717-21.

PMID:
12894564
30.

Detection of anti-livin antibody in gastrointestinal cancer patients.

Yagihashi A, Asanuma K, Tsuji N, Torigoe T, Sato N, Hirata K, Watanabe N.

Clin Chem. 2003 Jul;49(7):1206-8. No abstract available.

31.

A novel aspartate protease gene, ALP56, is related to morphological features of colorectal adenomas.

Tsuji N, Kondoh K, Furuya M, Kobayashi D, Yagihashi A, Inoue Y, Meguro T, Horita S, Takahashi H, Watanabe N.

Int J Colorectal Dis. 2004 Jan;19(1):43-8. Epub 2003 Jun 11.

PMID:
12802606
32.

Effect of topically applied basic fibroblast growth factor on injured cochlear nerve.

Sekiya T, Shimamura N, Yagihashi A, Suzuki S.

Neurosurgery. 2003 Apr;52(4):900-7; discussion 907.

PMID:
12657187
33.

A novel aspartic protease gene, ALP56, is up-regulated in human breast cancer independently from the cathepsin D gene.

Kondoh K, Tsuji N, Kamagata C, Sasaki M, Kobayashi D, Yagihashi A, Watanabe N.

Breast Cancer Res Treat. 2003 Mar;78(1):37-44.

PMID:
12611455
34.

The regulation of HGF and TGF-beta by an angiotensin II type 1 receptor antagonist in hepatic ischemia-reperfusion injury.

Araya J, Tsuruma T, Hirata K, Yagihashi A, Meguro M, Kawakami M, Yanai Y, Watanabe N.

Transplant Proc. 2003 Feb;35(1):107-10. No abstract available.

PMID:
12591328
35.

A novel gene containing PDZ and LIM domains, PCD1, is overexpressed in human colorectal cancer.

Furuya M, Tsuji N, Endoh T, Moriai R, Kobayashi D, Yagihashi A, Watanabe N.

Anticancer Res. 2002 Nov-Dec;22(6C):4183-6.

PMID:
12553053
36.

Selection of an internal control gene for quantitation of mRNA in colonic tissues.

Tsuji N, Kamagata C, Furuya M, Kobayashi D, Yagihashi A, Morita T, Horita S, Watanabe N.

Anticancer Res. 2002 Nov-Dec;22(6C):4173-8.

PMID:
12553051
37.

A proapoptotic caspase recruitment domain protein gene, TMS1, is hypermethylated in human breast and gastric cancers.

Moriai R, Tsuji N, Kobayashi D, Yagihashi A, Namiki Y, Takahashi H, Watanabe N.

Anticancer Res. 2002 Nov-Dec;22(6C):4163-8.

PMID:
12553049
38.

Enhanced expression of the UROC28 gene in human breast cancer: relationship to ERBB2 gene expression.

Kamagata C, Tsuji N, Kondoh K, Sasaki M, Kobayashi D, Yagihashi A, Watanabe N.

Anticancer Res. 2002 Nov-Dec;22(6C):4087-91.

PMID:
12553037
39.

Overexpression of early growth response-1 as a metastasis-regulatory factor in gastric cancer.

Kobayashi D, Yamada M, Kamagata C, Kaneko R, Tsuji N, Nakamura M, Yagihashi A, Watanabe N.

Anticancer Res. 2002 Nov-Dec;22(6C):3963-70.

PMID:
12553019
40.

Down-regulation of TRF1, TRF2 and TIN2 genes is important to maintain telomeric DNA for gastric cancers.

Yamada M, Tsuji N, Nakamura M, Moriai R, Kobayashi D, Yagihashi A, Watanabe N.

Anticancer Res. 2002 Nov-Dec;22(6A):3303-7.

PMID:
12530079
41.

Relevance of c-erbB2, PLU-1 and survivin mRNA expression to diagnostic assessment of breast cancer.

Izawa A, Kobayashi D, Nasu S, Saito K, Moriai R, Asanuma K, Nakamura M, Yagihashi A, Watanabe N.

Anticancer Res. 2002 Sep-Oct;22(5):2965-9.

PMID:
12530026
42.

Nimodipine ameliorates trauma-induced cochlear neuronal death.

Sekiya T, Yagihashi A, Asano K, Suzuki S.

Neurol Res. 2002 Dec;24(8):775-80.

PMID:
12500700
43.

Human beta-defensin-2 induction in Helicobacter pylori-infected gastric mucosal tissues: antimicrobial effect of overexpression.

Uehara N, Yagihashi A, Kondoh K, Tsuji N, Fujita T, Hamada H, Watanabe N.

J Med Microbiol. 2003 Jan;52(Pt 1):41-5.

PMID:
12488564
44.

Apheresis of immune diseases and apheresis using immunological specificity.

Yagihashi A, Kikuchi K.

Ther Apher. 2002 Oct;6(5):358-64.

PMID:
12423530
45.

Temporal pattern of cochlear nerve degeneration following compression injury: a quantitative experimental observation.

Shimamura N, Sekiya T, Yagihashi A, Suzuki S.

J Neurosurg. 2002 Oct;97(4):929-34.

PMID:
12405383
47.

A role for survivin in radioresistance of pancreatic cancer cells.

Asanuma K, Kobayashi D, Furuya D, Tsuji N, Yagihashi A, Watanabe N.

Jpn J Cancer Res. 2002 Sep;93(9):1057-62.

48.

Endogenous reactive oxygen species is an important mediator of miconazole antifungal effect.

Kobayashi D, Kondo K, Uehara N, Otokozawa S, Tsuji N, Yagihashi A, Watanabe N.

Antimicrob Agents Chemother. 2002 Oct;46(10):3113-7.

49.

Decreased gene expression for telomeric-repeat binding factors and TIN2 in malignant hematopoietic cells.

Yamada K, Yagihashi A, Yamada M, Asanuma K, Moriai R, Kobayashi D, Tsuji N, Watanabe N.

Anticancer Res. 2002 Mar-Apr;22(2B):1315-20.

PMID:
12168944
50.

Survivin mRNA expression in patients with breast cancer.

Nasu S, Yagihashi A, Izawa A, Saito K, Asanuma K, Nakamura M, Kobayashi D, Okazaki M, Watanabe N.

Anticancer Res. 2002 May-Jun;22(3):1839-43.

PMID:
12168879

Supplemental Content

Loading ...
Support Center